Arthritis Research & Therapy

official impact factor 4.36

This article is part of the supplement: Basic science, rationale, background and future of abatacept

The science of rheumatoid arthritis: a prelude

Josef S Smolen

Arthritis Research & Therapy 2005, 7(Suppl 2):S1-S3 doi:10.1186/ar1720

Accesses  

  • Last 30 days: 47 accesses
  • Last 365 days: 510 accesses
  • All time: 4652 accesses